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BRIEF REPORTS
Patient A is a 36-year-old man who presented 60 days after an Primary Lamivudine Resistance in Acute/Early Human acute retroviral syndrome that began 2 weeks after receptive anal
Immunodeficiency Virus Infection
intercourse with an unknown male partner. At the time of initial evaluation, the patient was well. Physical examination was entirely Primary resistance of HIV to zidovudine was first described in unremarkable. A test for HIV antibodies was positive. His baseline 1992 [1] and has since been identified in up to 10% of antiretroviplasma virus load was 136,000 copies/mL of plasma, and his CD4 ral-naive patients in some centers [2] . Primary resistance to neviracell count was 190/mL (figure 1A). Therapy was initiated with pine [3] has also been reported, but the prevalence of primary zidovudine (500 mg/day) and lamivudine (300 mg/day). At week resistance to other agents in widespread use in clinical practice in 8, the plasma virus load was 4,800 copies/mL. Saquinavir (enunknown. We now report two cases of primary lamivudine resishanced oral formulation, 3,600 mg/day) was added at week 10. tance in two antiretroviral-naive patients who presented with acute With this regimen, maximal virologic suppression was achieved HIV infection.
(õ400 copies/mL) and has been maintained to week 86, the most Patients with acute/early HIV infection (documented acquisition recent CD4 cell count being 1,020/mL. of infection in the previous 6 months) were recruited as part of Patient B is a 20-year-old man who presented 35 days after an an ongoing pilot study, initiated in March 1995. Patients have acute illness that followed sexual contact with a female partner. been recruited from community physicians, street clinics, sexually Physical examination revealed oral candidiasis. He received local transmitted disease clinics, cohort studies of gay or bisexual men therapy with nystatin (to which the candidiasis responded), and an and intravenous drug users, and high-risk persons admitted to hos-HIV antibody test was ordered, which was positive. Prior testing pital. At the time of the initial evaluation, a blood sample was earlier in the year had yielded negative results. His baseline plasma obtained for measurement of the CD4 cell count and the plasma virus load was 3,600 copies/mL, and his CD4 cell count was virus load (Amplicor HIV Monitor kit; Roche Diagnostics, Missis-380/mL (figure 1B). Therapy was initiated 5 weeks later with sauga, Canada).
zidovudine (500 mg/day) and lamivudine (300 mg/day). By week For resistance testing, HIV RNA was isolated from the base-3, the virus load had fallen to unquantifiable levels but then inline plasma sample and then reverse-transcribed and amplified creased to 970 copies/mL, and his treatment regimen was changed by use of primer NE1 (5-CCCACTAACTTCTGTATGTCAto stavudine (80 mg/day), didanosine (400 mg/day), and indinavir TTGACAGTCCAGCT-3) and primer A (5-TTGGTTGCA-(2,400 mg/day) and then changed again to stavudine and lamivud-CTTTAAATTTTCCCATTAGTCCTATT-3), respectively, unine at week 18 because of intolerance. His plasma virus load was der standardized conditions. Dilutions of this first PCR product õ400 copies/mL until week 36 and was then found to be 670 were used as templates for specific PCR-based detection of the copies/mL after a recurrence of genital herpes. Four months later, M184V mutation characteristic of resistance to lamivudine. This while the patient is receiving the same therapy, his plasma virus was done with primer 184 (5-GTAATCCCCACCTCAload is 53,000 copies/mL. ACAGA-3) and either primer 184M (5-CAGACATAGTTAIt is not surprising that the first cases of transmission of resistant TCTATCAATACG-3) or 184W (5-CAGACATAGTTATCTvirus strains involved isolates with decreased susceptibility to zido-ATCAATACA-3), designed to selectively amplify viruses with vudine [1] . Additional cases of primary drug resistance have been the appropriate mutation at codon 184 (184M) or wild-type slow to be identified but are now being described. The transmission HIV (184W). Experimental controls (provided by J. Mellors) of nevirapine-resistant HIV likely relates to the ease with which consisted of clinical plasma samples known to contain wildhigh-grade phenotypic resistance may develop in vivo [4] . A paraltype or mutant virus strains. Selective PCR findings were conlel can be drawn with lamivudine [5] . This study should not be firmed by formal sequencing of DNA obtained from the initial taken as a measure of the prevalence of primary lamivudine resisreverse transcription -PCR reaction.
tance in British Columbia, as our study population was largely The M184V mutation was identified at baseline in isolates taken unselected. It is of interest that none of 17 injection drug users from 2 of 35 patient samples. These consisted of 1 of 12 homosexevaluated had primary drug resistance, and this should be moniual men (patient A), 0 of 17 injection drug users, and 1 of 6 tored on an ongoing basis. heterosexual subjects (patient B).
The prospective mapping of spread of primary drug resistance (to lamivudine and any other agents) may allow us to follow the spread of HIV infection in specific groups or communities. planned at a national level in Canada to begin to address these The opinions and assertions contained herein are the private views of the issues.
Figure 1.
Serial plasma virus load measurements (copies/mL, ), CD4 cell counts (cells/mL, ᭺), and antiretroviral therapy administered to patients A and B, HIV-infected patients with virus isolates with primary resistance to lamivudine (ddI Å didanosine; D4T Å stavudine; IDV Å indinavir; SQV Å saquinavir; 3TC Å lamivudine; ZDV Å zidovudine).
. The patient rejected a cerebral biopsy. He coated by enlarged endothelial cells. Although BA is most frebecame clinically stable and was discharged while receiving treatment quently found localized to the skin [1, 2] , involvement of virtually with pyrimethamine and sulfadiazine. every organ system has been reported [1] . Pathologic findings in Six days after discharge, he was readmitted to the hospital because BPP include dilated capillaries and blood-filled cavernous (pelioof fever, widespread abdominal pain, vomiting, and anorexia. On tic) spaces involving the liver and spleen [1, 3] . We report a physical examination, the patient appeared severely ill, with a temperacase of an HIV-infected patient with massive hemoperitoneum and ture of 38.5ЊC, diffuse abdominal tenderness, and marked hepatomeghypovolemic shock as the main manifestation of hepatic BPP, aly. Neurological findings remained unchanged in relation to those complications not previously reported in this entity.
observed in the previous admission. The following laboratory values A 29-year-old man, seropositive for HIV, was admitted to the were noted: alkaline phosphatase, 2,774 U/L (normal range, 91-258 hospital because of fever and abdominal pain. The patient had a U/L); lactate dehydrogenase, 570 U/L (normal range, 230-460 U/L); WBCs, 1.8 1 10
fell to 64 g/L. Results of a panel of coagulation tests were normal. possible BA of the CNS [8] , the emergence of the skin lesions just after beginning treatment with erythromycin, and treatment failure An emergency laparotomy was done, revealing large amounts of blood in the abdominal cavity, with diffuse bleeding from the liver surface, with azithromycin. It is of interest that azithromycin has proved efficacious in cases of BA in patients with AIDS [9] . without evidence of any other bleeding lesion in the peritoneum or in any other organs. Histopathologic study of a liver biopsy sample This case report highlights the need for including BPP and BA in the differential diagnosis for HIV-infected patients with fever revealed the presence of extensive fibrous areas in the portal spaces, with proliferation of dilated capillaries, in association with extravasated and abdominal pain [2] , bleeding disorders [4, 5] , or CNS lesions [8] . Likewise, this case of spontaneous hemoperitoneum points out erythrocytes and siderophages. Infiltrates of polymorphonuclear cells with foci of karyorrhexis could be seen associated with hematosinophithe actual risk of hepatic hemorrhage in BPP. Theoretically, such a complication would be more probable if a percutaneous biopsy lic clumps containing small bacillary organisms revealed by WarthinStarry staining. The titer of IgG antibodies to B. henselae in serum of the liver were done, thus suggesting the selection of a different diagnostic specimen in these patients whenever possible [1, 5] shock. Although BPP and BA are vascular lesions known to cause 7. Steeper TA, Rosenstein H, Weiser J, Inampudi S, Snover DC. Bacillary epithelibleeding (e.g., hemorrhages of the gastrointestinal tract [4, 5] ), and oid angiomatosis involving the liver, spleen, and skin in an AIDS patient the peritoneum may be involved [6] , severe intraperitoneal bleeding with concurrent Kaposi's sarcoma. Am J Clin Pathol 1992;97:713-8.
has not yet been reported. The histologic findings in our case differ background, all features previously described [7] . Likewise, other re- markable peculiarities of the reported case were its clinical onset as Often, no etiologic agent can be identified, and persistent fever is
Persistent Fever as the Only Manifestation of Chronic
interpreted as being due to HIV-1 [1] . We report here the case of
Coxsackievirus B4 Infection in the Brain of a Human
an HIV-1-infected child, in whom persistent fever was the only
Immunodeficiency Virus Type 1 -Infected Child at 4 years his therapy was changed to didanosine. Five months progressively worsened until he became comatose, and the child died 6 weeks after the beginning of neurological disturbances. later, the child began having recurrent diarrhea with weight loss, leading to an overt wasting syndrome at 5 years of age. Combined According to the U.S. Centers for Disease Control and Prevention indications [1] , persistent fever is considered a typical HIVtherapy with zalcitabine and saquinavir did not result in any clinical or immunological improvement. At 5 1 2 years, after a relatively 1-associated clinical manifestation in infected children. However, symptom-free period, he developed remittent fever unresponsive doubts arise as to whether HIV-1 by itself can cause fever. Fever to broad-spectrum antibiotics. No signs of sepsis or localized infecdoes not manifest in subjects with high virus loads but mild immution were found. Abdominal echography and chest radiography nodeficiency, whereas it does in patients with severe immunosupwere normal. His WBC count was 4.5 1 10 9 /L and his C-reactive pression [3] who are thus at high risk for secondary infections. protein level was õ3 mg/L. Repeated cultures for bacteria, fungi, Common infections may have an atypical presentation and an unviruses, and protozoa from blood, stool, and urine were negative; usual course in immunocompromised subjects. Agammaglobulinserological tests for infectious agents were unremarkable. After 35 emic patients may develop chronic enterovirus meningoencephalidays of fever, CSF analysis revealed the following values: WBCs, tis with an indolent course [2] . HIV-1-infected children have a 60 1 10 6 /L (70% mononuclear cells); protein, 74 mg/dL; and significant humoral immunodeficiency, which may account for the glucose, 51 mg/dL. Cultures from CSF, including those for enterochronic coxsackievirus B4 meningoencephalitis in our patient. viruses, were negative. Coxsackievirus B4 was detected by a PCR Chronic viral infections in the brain without neurological disturassay; the virus was not found in stool and throat washings either bances for prolonged periods may be more frequent than is usually by culture or by PCR. Electroencephalography showed mild difthought in children with HIV-1 infection. Another of our patients fuse aspecific abnormalities, and a cranial CT scan showed mild recovered from measles, but the persistence of the virus in his dilatation of subarachnoid spaces.
brain led to subacute meningoencephalitis 2 months later [4] . Transient or long-lasting effects of high doses of intravenous
In conclusion, in HIV-1-infected children with unexplained feimmunoglobulins have been reported in agammaglobulinemic chilver, targeted investigations for viral infections in the brain should dren with chronic enterovirus meningoencephalitis [2] . Intravenous be considered, even in the absence of neurological signs. immunoglobulin (1 g/kg; Endobulin; Immuno, Vienna) and thymopoietin (25 mg; Timunox; Cilag, Schaffhausen, Switzerland) were E. Palomba and P.-A. Tovo infused on each of 6 consecutive days, twice a week for 1 month, 
Postexposure Rabies Vaccination in Patients Infected
infected persons with these antigens may induce a normal antibody with Human Immunodeficiency Virus response when undertaken early in the disease [4] [5] [6] . Although HIV-infected persons require special consideration because of conIn general, symptomatic HIV-infected children and adults have cern that their response to vaccine may be abnormal, the vaccinasuboptimal immunologic responses to several commonly used vaction of HIV-infected persons against tetanus, diphtheria, pertussis, cines [1] [2] [3] [4] [5] . Previous studies demonstrated impaired formation of poliomyelitis, hepatitis B, influenza, and pneumococcal disease antibodies to T lymphocyte-dependent antigens (such as diphthehas been recommended [7] . ria, tetanus, poliovirus, and influenza vaccines) in relation to the There is little doubt that postexposure rabies vaccination prevents deaths in persons who are exposed to rabies, so it differs from other immunizations in that it represents treatment for a fatal disease. Because the aim of postexposure rabies vaccination is to / T lymphocyte counts have an impaired (primary) antibody response after receipt of tissue culture rabies vaccines as recommended by WHO. We recommend that it is necessary to check titers of neutralizing antibody to rabies virus in HIV-infected patients after postexposure rabies vaccination with tissue culture rabies vaccine. Higher doses or more frequent booster injections may be considered for HIV-infected patients; however, the response to higher doses of rabies vaccine and the persistence of neutralizing antibodies in these patients have not been evaluated. Recently, we decided to double the dose of tissue culture rabies vaccine in HIV-infected persons exposed to rabies. This practice at our institution is needed to determine whether this will result in an adequate neutralizing antibody response. / T lymphocyte counts of £300/mL (range, 111 -250/mL) (X) Amphotericin B has been suggested as the treatment of choice for cerebral histoplasmomas, but it is effective in only about half of cases [1] . In the review by Wheat et al. [1] , no cases of cerebral histoplasmomas resolved without antifungal therapy, and only two were treated with azoles. I am unaware of previous reports of itraconazole use for CNS histoplasmosis.
A 53-year-old woman with a history of type II diabetes mellitus presented with a 3-week history of confusion, dysarthria, rightsided weakness, left-sided eyelid ptosis, weakness of gaze to the right, right-sided hyperreflexia, and left-sided neglect. She denied having chills or sweats and was afebrile.
Four months earlier, she had had a platelet count of 5,000/mm 3 and was treated with corticosteroids and intravenous immunoglobulin for idiopathic immune thrombocytopenia. During that time, she had a brief febrile illness; a bone marrow examination revealed noncaseating granulomas, and a chest radiograph showed increased interstitial markings. Her platelet count, fever, and chest radiograph returned to normal after a few days, and corticosteroid treatment was tapered and then discontinued 3 weeks before her neurological symptoms began. Figure 1 . Post -gadolinium contrast T 1 -weighted axial cerebral At the time of her neurological symptoms, an MRI scan revealed MRI in a 53-year-old patient with cerebral histoplasmomas. numerous lesions (diameter, õ1 cm) of the grey and white matter of the frontal, parietal, and occipital lobes and lesions within the midbrain and brain stem (figure 1). The lesions enhanced after revealed a decrease in the number and size of the lesions and in intravenous injection of gadolinium, and some had surrounding the surrounding edema. She continued to receive itraconazole for edema. An abdominal CT scan showed the left adrenal to be 3. 4 1 year. Another MRI scan done 4 months after discontinuation of 1 3.9 cm with a hypodense center and hyperdense rim. A chest therapy revealed no change from the scan at the end of therapy. radiograph was normal. A fine-needle adrenal aspirate showed More than 2.5 years after discontinuing therapy, the patient renondiagnostic results. On CSF testing, the following values were mains asymptomatic. noted: glucose, 52 mg/dL; protein, 61 mg/dL; RBCs, 0/mm 3 ;
The patient described had evidence of cerebral histoplasmomas, WBCs, 1/mm 3 (100% mononuclear). Bone marrow and CSF culdespite the lack of a brain biopsy. H. capsulatum was found in tures were negative. The Histoplasma capsulatum polysaccharide the adrenal gland, antibodies to H. capsulatum were present in antigen level in serum was 0.5 U and in CSF was 0.7 U. The CSF, and the lesions and symptoms responded to antifungal therpatient was negative for IgG antibodies to Echinococcus species apy. Negative cultures of CSF and a negative result on CSF hisand HIV and IgM antibodies to Toxoplasma species in serum. Her toplasma polysaccharide antigen testing are observed in about half serum was positive for IgG antibodies to Toxoplasma species, but of cases of CNS histoplasmosis [1] . It is likely that her disease the ratio of Toxoplasma IgG antibodies to total IgG was twofold was related to the immunosuppressive effects of the corticostegreater in serum than in CSF. Her titer of complement fixation roids, despite discontinuation of corticosteroids 3 weeks before antibody to H. capsulatum in CSF was 1:2 for the mycelial antigen her neurological symptoms began. and 1:4 for the yeast antigen. An open adrenal biopsy revealed Two cases of cerebral histoplasmomas have been successfully extensive necrosis, granulomatous inflammation, and organisms treated with ketoconazole after relapse following therapy with inconsistent with histoplasmosis. Culture of adrenal tissue yielded travenous amphotericin B [2, 3] . There has also been a report of H. capsulatum. treatment failure with ketoconazole therapy for cerebral histoplasThe patient refused therapy with amphotericin B. She began momas [4] . Ketoconazole has been associated with treatment failreceiving itraconazole, 200 mg three times daily for 3 days, folures in immunocompromised patients with histoplasmosis and has lowed by 200 mg twice daily. Her neurological signs and symppoor penetration into CSF [1] . Two reported cases of CNS histotoms improved over the next 3 months, and repeat MRI scans plasmosis have been treated with fluconazole, which crosses the blood-brain barrier, but the length of follow-up was short [5, 6] . Fluconazole is associated with treatment failures and relapses in both immunocompetent and immunocompromised patients with non-CNS histoplasmosis [7, 8] . In animal models, concentrations 
Carbapenem-Resistant Acinetobacter baumannii with
Meropenem was discontinued, and intraventricular tobramycin (10
Intraventricular Colistin Sulfomethate Sodium
mg/12 h), intravenous tobramycin (5 mg/kg once a day), and intravenous sulbactam (2 g/6 h) were then initiated. On day 19, because CSF Over the past 2 decades, Acinetobacter baumannii has develcultures remained positive, the ventriculostomy tube was replaced and oped one of the most alarming patterns of antibiotic resistance intraventricular tobramycin was switched to intraventricular colistiever observed [1] . Nowadays, since an increasing proportion of methate sodium (5 mg/12 h), intravenous tobramycin was maintained, isolates are resistant to all antibiotics tested routinely, therapy is and intravenous sulbactam was discontinued. Intraventricular colistin a serious challenge [2] . Beginning in 1992, a large outbreak due was administered in a 5-mL solution of saline serum through the to multiresistant A. baumannii was noted in our 1,000-bed tertiary ventriculostomy tube after previous extraction of 5 mL of CSF, and teaching hospital, causing considerable imipenem overuse [3] . In thereafter, the drainage was interrupted for 3 hours. On day 21, culJanuary 1997, two clones resistant to carbapenems emerged: clone tures of CSF were negative and remained so until colistin sulfometh-D, moderately resistant to imipenem (MICs, 4-16 mg/L) and toate sodium therapy was ended on day 39, when a ventriculoperitoneal bramycin (MIC, 8 mg/L) and susceptible only to sulbactam and shunt was inserted. During therapy, CSF bactericidal titers at 3 hours polymyxins (MICs, £4 mg/L), and clone E, highly resistant to after colistin sulfomethate sodium administration (peak) were 1/2, imipenem and sulbactam (MICs, ú256 mg/L), moderately resisand before doses were administered (trough), titers ranged from tant to tobramycin (MIC, 8 mg/L), and susceptible only to poly-õ1/2 to 1/4. Similarly, CSF bacteriostatic titers at peak were 1/8 and myxins. Since then, five patients have developed catheter-associat trough ranged from 1/4 to 1/16. Levels of tobramycin in CSF varied ated ventriculitis due to carbapenem-resistant A. baumannii strains from 7.9 mg/L (peak) to 0.7 mg/L (trough). No adverse reactions were (table 1). Of these five patients, three died of their infection after documented during therapy. On day 82, the patient was alert with receiving inadequate therapy (patients 1-3). The other two are, to spontaneous mobilization of the extremities, but he died suddenly of our knowledge, the first reported to date who survived after treatcardiac arrest. Postmortem examination ruled out ventriculitis, and ment with intraventricular colistin sulfomethate sodium (patients cultures of CSF were negative for A. baumannii. 4 and 5).
Patient 5 was a 34-year-old woman who required an external Patient 4 was a 16-year-old boy who underwent surgery and the ventriculostomy tube because of subarachnoid hemorrhage with insertion of an external ventriculostomy tube for continuous drainage hydrocephalus. The catheter was removed 6 days after insertion; because of hemangioblastoma of the fourth ventricle. On day 7 after however, 24 hours later, the patient developed high fever and surgery, meropenem at 2 g/8 h was started empirically to treat his neurological symptoms worsened, with purulent secretion from the fever, although CSF cultures had been sterile. On day 16, his fever catheter insertion site. CSF obtained through a new ventricular drainage site was cloudy, showing 2,000 cells/mm 3 (95% polymorphonuclear cells) and short gram-negative rods on gram stain. was observed, cultures of CSF remained positive through the fifth In view of these results, search for new therapeutic strategies is urgently needed for the treatment of CNS infections due to day of therapy. Dosages of colistin sulfomethate sodium were then increased to 10 mg/12 h, and 24 hours later, cultures of CSF A. baumannii that is resistant to carbapenems. In the meantime, intraventricular colistimethate sodium may be life-saving in ciryielded negative results (CSF peak bactericidal and bacteriostatic titers were õ1/2 and 1/16, respectively). Cultures of CSF contincumstances in which there are no other options. ued to be negative until day 30 of the patient's stay in the intensive care unit (6 days after the end of colistin sulfomethate sodium P. Fernandez-Viladrich, X. Corbella, L. Corral, F. Tubau, therapy), when a ventriculoperitoneal shunt was inserted. Two and A. Mateu months later, the patient was discharged from the unit, remaining A. baumannii infections; however, no antibiotic alternatives have been defined for cases of infection due to carbapenem-resistant strains. Therapy in these patients is severely threatened and cur-contamination [6] . In contrast, patients with systemic lupus erytheAdult Pneumococcal Cellulitis: Case Report and Review matosus, nephrotic syndrome, and hematologic disorders, including multiple myeloma and macroglobulinemia, commonly present Streptococcus pneumoniae is an infrequent cause of skin infecwith face and neck cellulitis [1] [2] [3] [4] 7] . Pharyngeal colonization has tions in adults. Prior reports describe facial cellulitis in children been postulated to be the initiating event for facial cellulitis bewith hypogammaglobulinemia and hemoglobinopathy and in cause of the proximity to the respiratory tract [1] . The age distribuadults with connective tissue disorders [1, 2] . We report a case of tion correlated with the patient's underlying disease. The male-topneumococcal cellulitis and bacteremia in an alcoholic patient with female ratio was Ç2:1. diabetes and discuss this disease in adult patients.
Pneumococcal cellulitis was universally associated with bacter-A 71-year-old man with a history of alcohol abuse presented emia [2] [3] [4] [5] 7] . Penicillin was typically the drug of choice. Thus with fever and a 4-week history of intermittent and progressive far, only one reported case was due to penicillin-resistant S. pneupain in the right lower extremity associated with skin discoloration.
moniae [7] . The role of pneumococcal vaccination is difficult to He denied any history of trauma or respiratory illness. He had not ascertain, since administration was not reported and most patients previously received polyvalent pneumococcal vaccination.
would be expected to have a poor antibody response. On admission, the patient was febrile to 38ЊC, lethargic, and Suppurative complications were common, and surgical intervenconfused. Bullae, a violaceous hue, and multiple areas of desquation was required in many cases [2] [3] [4] 6] . Procedures included mation were noted on the right foot and lower leg. The lower leg debridement, fasciectomy, amputation, and skin grafting. Mortality was warm and tender, whereas the foot was cold and pulseless.
was cellulitis in persons with diabetes and substance abuse. BloodThe patient underwent a below-knee amputation. Histopathostream invasion, tissue necrosis, and suppurative complications are logic evaluation revealed diffuse polymorphonuclear infiltration of common. Thus, a clinician should have a high degree of suspicion the soft tissue, gram-positive diplococci, and acute thrombophlebiof pneumococcal cellulitis for patients who present with cellulitis tis with acute inflammatory infiltrates of arterial adventitia consisassociated with bullae and violaceous color, to allow for the initiatent with cellulitis. The patient was treated with vancomycin. He tion of early, aggressive management. underwent a subsequent above-knee amputation because of poor stump healing. / 9c64$$ap73 03-16-99 08:25:44 cida UC: CID
Recrudescence of Cutaneous Mycobacterium haemophilum Lesions Following Tetanus Immunization
Mycobacterium haemophilum is increasingly recognized as a cause of cutaneous, joint, and pulmonary infections in immunocompromised hosts [1, 2] . We describe a patient with HIV infection and cutaneous lesions due to M. haemophilum who experienced an unusual reaction to a routinely administered tetanus vaccine.
In August 1996, a 51-year-old homosexual man was diagnosed with Pneumocystis carinii pneumonia and treated successfully with trimethoprim-sulfamethoxazole (TMP-SMZ). He declined formal HIV testing, choosing instead to travel in search of nontraditional healing strategies. While in Thailand in April 1997, he noted the subacute onset of tender, erythematous nodules on his extremities. He returned to the United States and presented to the hospital, where he reported intermittent fevers and weight loss. Physical examination revealed a temperature of 39.0ЊC, temporal wasting, and oral candidiasis. There were multiple violaceous, tender, and fluctuant nodules on his legs (figure 1). A chest radiograph was normal. The WBC count was 3,000/mm 3 , and testing for antibody to HIV was positive. The absolute CD4 count was 4/mm 3 , and the plasma HIV RNA was 432,000 copies/mL.
Aspirates from skin lesions were heavily laden with acid-fast bacilli. The patient was initially treated with isoniazid, rifampin, ethambutol, and pyrazinamide until DNA probes ruled out Mycobacterium tuberculosis. Specimens subcultured on chocolate agar at 30ЊC yielded growth after 1 month. Gas-liquid chromatographic analysis of the cell-wall fatty acids produced a pattern consistent with M. haemophilum, and the patient was treated with clarithromycin, TMP-SMZ, rifabutin, and ciprofloxacin. He also received the antiretroviral medications stavudine, lamivudine, and nelfinavir. By July 1997, the lesions were greatly improved; his CD4 count had risen to 64/mm 3 , and plasma HIV RNA was undetect- Figure 1 . Skin lesions caused by Mycobacterium haemophilum in able. As part of a routine clinic visit, he was given an intramuscular a 51-year-old HIV-infected man. injection of tetanus toxoid. Within 1 day, he noted the rapid recurrence of the nodular lesions on his legs. Aspirates of these lesions 1 week later again revealed many acid-fast bacilli. However, of M. haemophilum and the absence of viable organisms from the plasma HIV RNA remained undetectable, and the CD4 count was recurrent lesions, it is unlikely that this recrudescence represented 95/mm 3 . The patient was observed while taking the same regimen resurgence of infection. Rather, this case illustrates a previously of antiretroviral and antimycobacterial medications, and after sevunrecognized effect of tetanus vaccination in the setting of imeral weeks the lesions again slowly resolved. Cultures from the mune-system restoration. second aspirate remained negative.
The phenomenon of inflammatory reactions resulting from M. haemophilum has been reported as a cause of lymphadenitis newly competent immune cells has been recognized in HIVin otherwise healthy children, and is now recognized as a pathogen infected patients since the advent of potent antiretroviral therapy, of immunocompromised adults [1, 2] . Because of the organism's and has been particularly noted with mycobacterial infections [4] . propensity for growth at reduced temperatures, skin lesions are
In the case presented here, the combined medication regimen iniusually found on the extremities. Optimal treatment is unknown, tially resulted in successful treatment of both mycobacterial and and the prognosis appears to be closely linked to the degree of HIV infections. The return of functional CD4 cells is supported underlying immunosuppression [1] [2] [3] . The rapid recrudescence of by the near resolution of the M. haemophilum skin lesions, which to such skin lesions has not been reported. Given the slow growth date has been rare in AIDS patients [3] . However, the vaccination provided a sudden immune stimulus, presumably secondary to CD4-cell activation by the T-cell dependent tetanus toxoid. The resulting skin lesions, although now sterile, were no less dramatic. /L on day 9. An esophagogastroscopy done on day 17 revealed on theoretical rationale, limited clinical trial data, and the opinions a necrotic esophageal ulcer (1 cm by 10 cm). CMV and HIV were of experts. We describe a patient with concurrent primary HIV-1 cultured from biopsy material. Neither staining nor culture showed and cytomegalovirus (CMV) infections who had severe neutroevidence of fungal etiology. CMV inclusion bodies could not be penia while receiving antiretroviral therapy.
identified. Ganciclovir was started and the retrosternal pain quickly Serologies for antibodies to CMV and HIV and testing to deterabated. mine plasma HIV RNA viral load (Amplicor HIV Monitor Test, On day 15, the patient's WBC count was 3. /L and the CD4/ lymphocyte count to 0.607 1) because of fever of 12 days' duration, headache, skin rash, and 1 10 9 /L by day 25, when saquinavir (1,800 mg/d) was added. The enlarged cervical lymph nodes. She had been prescribed acyclovir patient tolerated stavudine, lamivudine, and saquinavir and was for suspected genital herpes infection 9 days earlier. Her history discharged to her home. On day 54, her WBC count was 4.9 1 revealed two episodes of condom-protected heterosexual inter-10 9 /L (neutrophils, 2.6 1 10 9 /L), CD4/ lymphocyte count was course 2 weeks before the fever. She had been HIV-negative 4 0.640 1 10 9 /L, and her plasma HIV RNA viral load was 2,200 months earlier, and she denied other possible exposures to HIV copies/mL. A serology for antibodies to HIV showed strong reacthereafter. On hospital day 1, serologies for antibodies to HIV tions to gp 41 and gp 120, but no reaction to p34. A serology showed a distinct reaction to envelope protein gp 41 and weak for IgG antibodies to CMV was positive. Esophagogastroscopy reactions to envelope protein gp 120 and to protein p 17, the plasma findings were within normal limits. HIV RNA viral load was 480,000 copies/mL, and a serology for
The cause of neutropenia in our patient was probably multifactoantibodies to CMV was negative. On day 3, her WBC count was rial; antiretroviral agents, two acute viral infections, and sepsis may 3.6 1 10 9 /L (neutrophils, 1.1 1 10 9 /L), hemoglobin level was 127 have contributed to neutropenia. There was no definite histological g/L, and her platelet count was 188 1 10 9 /L. On day 5, therapy proof for CMV causing the esophageal ulcer, but positive culture with zidovudine (600 mg/d), lamivudine (300 mg/d), and indinavir from biopsy material, CMV seroconversion, and response to gan-(2,400 mg/d) was instituted, and fluconazole and famotidine were ciclovir supported this diagnosis. started for oral thrush and retrosternal pain, respectively. On day Ten cases of HIV and CMV primary coinfections have been described. In general, HIV infection seemed to progress rapidly, as measured by the decline in CD4 cell counts. Several patients had complications during the primary disease. One patient had 
Lanka condition improved and the radiological evolution of the pulmonary and brain lesions was favorable. The patient had no recrudesMelioidosis is an infection caused by the soil and water bactecence of melioidosis during 2 years of follow-up. rium Burkholderia pseudomallei. Melioidosis is endemic in
This case of melioidosis is intriguing because of its clinical Southeast Asia and Northeast Australia [1] . Occasionally tourpresentation and geographic origin. The disease was acquired ists who have traveled for a limited period in an area of endemicby a tourist who traveled in a region that was considered nonenity, such as the northern part of Thailand, may develop melidemic [1] . Indeed, only very few cases of melioidosis have been oidosis [2] . Herein, we describe a patient who had acute reported from the Indian subcontinent or Sri Lanka, despite melioidosis, with necrotizing pneumonia and a brain abscess, similarities in geographic location, weather, and environmental that occurred after travel to Sri Lanka, a region that was considconditions with Southeast Asian countries. Melioidosis may, ered nonendemic [1] .
however, be underdiagnosed because of difficulties in cultur-A 66-year-old man with a negative medical history traveled in ing the causative microorganism or may be misdiagnosed as Sri Lanka for 15 days. He returned to Europe 2 days before the plague [3] . onset of fever (temperature, 39ЊC) and headache. He was treated
The common clinical presentations of acute melioidosis are sepinitially with paracetamol. Ten days after onset of symptoms, the sis and pneumonia. Neurological involvement is infrequent [4] . patient was admitted to the hospital because of persisting fever
Only one other case of melioidosis brain abscess acquired during and increasing stupor and disorientation. There was no nuchal travel has recently been described [5] . The patient we describe, rigidity. A CT scan of the head revealed a frontal lobe mass. A with multiple organ involvement, was treated with ceftazidime chest radiograph and CT scan showed an infiltrate with central followed by a prolonged maintenance treatment with ofloxacin. necrosis in the right upper pulmonary lobe. Direct microscopy of Ceftazidime has been shown to halve the mortality rate of acute a specimen obtained by CT-guided aspiration of the pulmonary melioidosis and has become first-choice antibiotic for treatment of lesion revealed polymorphonuclear WBCs; there were no bacteria severe melioidosis [6, 7] . Fluoroquinolones have been used for evident on gram-staining of the aspirate. Culture of the aspirate treatment of melioidosis, but recent experience indicates that priyielded B. pseudomallei. The strain was susceptible to ceftazidime mary treatment failures and relapses are more frequent than with (MIC, 1.0 mg/L), imipenem (MIC, 0.09 mg/L), and ciprofloxacin a conventional antibiotic combination [8] . The main reasons for (MIC, 0.5 mg/L). Serology for B. pseudomallei (agglutination these failures may be the marginal in vitro activity against most assay) performed at the Pasteur Institute (Paris), showed a titer of isolates of B. pseudomallei and the emergence of resistance during 1:320. Antibiotic treatment with ceftazidime (2 g iv t.i.d.) was treatment. The favorable response of our patient may be due to the lower MIC, the higher dose of the fluoroquinolone, and a longer primary treatment with ceftazidime compared to the experience in the literature. 
Candida (Torulopsis) glabrata: A New Pathogen Found in an Empyema
A 75-year-old man presented to the emergency department because of epigastric pain, nausea, and vomiting after consuming dinner. On initial presentation he was afebrile. He had diffuse abdominal tenderness with guarding. His physical examination findings were otherwise normal. The WBC count was normal with no left shift. His chest radiograph revealed a small left-lowerlobe infiltrate, for which he was started on intravenous ampicillin/ sulbactam. An abdominal series revealed no evidence of obstruction. An exploratory laparotomy showed no significant pathology. Within 24 hours following the operation, a closed chest-tube thoracostomy was performed because of the development of an expanding massive left pleural effusion with compression atelectasis. Microscopic evaluation of a pleural-fluid specimen revealed a The patient we described represents the first reported case of pleural biopsy. Gram staining of the biopsy specimens and empypleural empyema associated with C. glabrata. His presentation ema (figure 1) revealed a yeast-like organism, and cultures yielded is interesting, as others have also reported infection due to C. glabrata. Blood cultures were positive once for C. glabrata C. glabrata with an initial presentation of gastroenteritis [1] . and three times for Staphylococcus aureus, for which the patient Although the upper airway is an important portal of entry for was treated with intravenous vancomycin. A serology for antibody Candida species, pneumonia due to Torulopsis species is very rare [1, 2] . Several cases of pneumonia due to Torulopsis species associated with fungemia have been reported, but the pulmonary infection was not believed to be the etiology of the fungemia Toledo, Ohio
Gas Gangrene in an Immunocompromised Girl Due to a Clostridium ramosum Infection
Clostridia are gram-positive, spore-forming anaerobic rods. A number of Clostridium species that are normally present in the commensal flora of the human intestine may cause infections. Severe infection of soft tissue results in gas gangrene or myonecrosis. Such infections occur after traumatic injuries as well as spontaneously. Spontaneous nontraumatic gas gangrene is either locally associated with an intraabdominal focus or a distant spread of infection. These infections occur mainly in immunocompromised hosts. Clostridium septicum is the Clostridium species isolated most frequently in nontraumatic gas gangrene in patients with malignancies of the gastrointestinal tract and leukemia, and in children with cyclic neutropenia [1, 2] . In patients colonized with Figure 1 . Radiograph of the thorax of an 11-year-old immunocom-C. septicum, it appears that neutropenia predisposes to the developpromised patient with an infection due to Clostridium ramosum. Interment of bacteremia. Clostridium ramosum is one of the Clostridstitial emphysema is seen in the right axilla (black arrow) and the ium species that is often isolated from stool samples of children, superior mediastinum (white arrows). but has been associated only rarely with severe infections or bacteremia [3, 4] . The number of cultures positive for C. ramosum is probably underestimated. The organism can easily be missed in ture of 40.5ЊC, a pulse rate of 160 beats/min, and a blood pressure anaerobic cultures, because it usually stains gram-negative instead of 80/45 mm Hg. A chest radiograph revealed no signs of pulmoof gram-positive, and the typical terminally located spores are nary infection or congestion, but showed an interstitial emphysema sometimes hard to detect. We describe a lethal septic episode in in the right axilla and the superior mediastinum ( figure 1 ). This an immunocompromised child with spontaneous gas gangrene and finding was confirmed by ultrasonography. Laboratory findings cultures of blood yielding C. ramosum and Candida albicans.
showed leukocytopenia (WBC count, 100 1 10 6 /L), thrombocytoAn 11-year-old girl had been receiving chemotherapy for several penia (platelet count, 12 1 10 9 /L), and anemia (hemoglobin level, weeks because of the recurrence of a common acute lymphatic 4.1 mmol/L). There was diffuse intravascular coagulation (partial leukemia and was in a neutropenic phase (WBC count, 200 1 thromboplastin time, ú40 sec; activated partial thromboplastin 10 6 /L). While at home, she developed a severe mucositis, and her time, ú150 sec). The sodium level was 128 mmol/L, potassium condition deteriorated in the days before she was admitted to the level was 6.9 mmol/L, total bilirubin level was 750 mmol/L, and hospital. She had fever, chills, myalgia, loss of appetite, and walactate level was 11.6 mmol/L. tery, bloody diarrhea. Physical examination at admission revealed Only one blood culture set (anaerobic/aerobic) could be oba sick, somnolent, dyspneic girl with yellow sclerae and several tained. In both bottles, microbial growth was noted after 24 hours. greenish necrotic ulcers on the tongue. Her face and neck were Gram staining of the anaerobic bottle specimen demonstrated swollen with palpable crepitations of the skin. She had a temperagram-negative rods with typical terminal spores. Subculture on blood agar plates yielded growth only anaerobically after 48 hours. The isolate was nonmotile, unable to produce indole, and able to ferment maltose, salicine, lactose, sucrose, and mannitol, and was, In the pediatric intensive care unit, the girl was treated for septic that may facilitate mucosal penetration [9] . The (oral) mucositis in our patient-a common feature in patients treated with chemoshock. Vancomycin (40 mg/kg), gentamicin (6 mg/kg), ceftazidime therapy-was most likely the portal of entry and may have en-(100 mg/kg), and dexamethasone (stress doses) were administered hanced intravascular invasion with C. ramosum and probably also intravenously, and she received circulatory and respiratory support.
with C. albicans. Whether the fungemia due to C. albicans played In spite of maximal treatment she died within 1 hour of admission. a role in the fatal outcome of the acute infection in this patient The presumptive diagnosis was spontaneous gas gangrene with remains unclear. circulatory failure. The diagnosis could not be confirmed because autopsy was not permitted.
E. R. van der Vorm, I. A. von Rosenstiel, L. Spanjaard, and To our knowledge, we have described the first case of a fatal J. Dankert infection due to C. ramosum in a child with leukemia and chemo- In healthy persons, C. albicans is frequently isolated from gas- 
Mycobacterium fortuitum in an Immunocompetent Patient
peared 2 months earlier on the right arm and had persisted despite local disinfection. Gradually, the other arm, the trunk, and the neck Cutaneous infections due to atypical mycobacteria are well had become involved ( figure 1 ). There was no pruritus or fever. known. However, the frequency of rapidly growing mycobacteria Oral antibiotics were administered (oxacillin, 2 g per day for 1 is probably underestimated. Cutaneous or soft-tissue infections are week, followed by pristinamycin, 3 g per day for 2 weeks) with the most frequent human diseases caused by these microorganisms. no improvement. There was no history of previous surgery, trauma, The lesions are usually nodular, ulcerative, or cellulitic. To our or injection. The clinical examination did not reveal lymph node knowledge, we describe the first case of a disseminated papulopusinvolvement or hepatosplenomegaly. Blood cell count, lymphotular eruption due to Mycobacterium fortuitum without associated cytic phenotyping, profile of ion concentration, hepatic and renal systemic infection in an immunocompetent patient.
function, as well as chest radiographs and abdominal ultrasonography were normal. A serology for antibodies to HIV was negative. Cultures of two different specimens from two pustules obtained at 2-week intervals both yielded mycobacteria within 5 days. The neous lesions may also follow a systemic infection. Immunocompetent patients develop cellulitic, nodular, or ulcerative lesions. Extensive necrosis and abscess formation are more often encountered in immunocompromised patients. A satellite pathologic lymph node is generally noted. To our knowledge, only one case of maculopapular eruption due to a rapidly growing mycobacterium has been reported, accompanied by disseminated infection, which was not observed in our case [5] . Therefore, we have described the first case of profuse papulopustular eruption due to M. fortuitum, without systemic involvement, occurring in an immunocompetent patient. The particular occupational context (a marine electrician often exposed to microtraumas in stagnant water) probably explains this kind of eruption with its particular disseminated variety. The partial regression of the lesions after 2 months of bi-antimicrobial therapy could be explained by a lower sensitivity of the microorganism in vivo than in vitro. Alternatively, the partial efficacy of the treatment to 40ЊC on routine bacteriologic media [2] . In this group, only water [3, 4] . More than 90% of cutaneous diseases caused by nae is mostly responsible for disseminated infections [5] . The 718 -20. organisms gain entry into a host by inoculation into the skin and 
Torovirus Gastroenteritis Presenting as Acute Abdomen
virus-like particles in children and adults with gastroenteritis [4] [5] [6] [7] . It was further shown in a case-control study that torovirus Toroviruses are enveloped, positive stranded RNA viruses that was definitively associated with hospital-acquired gastroenteritis are classified as members of the family Coronaviridae [1] . They in children [8] . The detection of toroviruses by use of electron have been shown to be etiologic agents of gastroenteritis in cattle, microscopy has been substantiated by EIAs using antisera to Breda and a porcine torovirus has recently been reported [2, 3] . There virus, a bovine torovirus, and by immunospecific and molecular approaches [5, 7] . Herein we describe two patients who presented with gastroenteritis as well as with signs of acute surgical abdomen. In both patients, the detection of torovirus in the stool speci- Patient 1 was a 9-year-old girl with familial Mediterranean fever with daily colchicine therapy. She presented with a 1-day history Torovirus has been reported in association with human gastroenteritis [6, 8] . These studies showed that the virus can be detected in of fever (temperature, to 39ЊC) that resolved the following day, when she developed recurrent bouts of severe colicky abdominal stool specimens of symptomatic patients by use of electron microscopy and ELISA. Torovirus has recently been shown to be a relapain, each lasting 30 to 60 minutes; she was pain free between the episodes. Accompanying the abdominal pain were vomiting tively common agent of diarrhea [6, 8] . Clinically, torovirus-induced gastroenteritis is similar to other types of viral gastroenteritis and and loose watery stools without frank or occult blood. On physical examination, she was afebrile and looked well except during the presents with abdominal pain associated with vomiting and diarrhea; fever may be present at the onset. The disease is self-limited and painful abdominal attacks when she was in significant distress. The abdominal examination revealed generalized tenderness, with resolves within several days, although shedding of the virus may continue for weeks, particularly in immunocompromised hosts [8] . involuntary guarding, positive rebound sign, and reduced peristaltic sounds. There was no hepatosplenomegaly. The remainder of Torovirus was the principal identifiable cause of nosocomial diarrhea in immunocompromised patients and in this regard patient 2, whom the physical examination findings were within normal limits. This patient was not considered to be having an episode of FMF, since we have described, was immunosuppressed [8] . An antibody response to the virus develops in more than one-half of the patients; the clinical presentation differed from those during her previous attacks. She was afebrile and the pain was intermittent and not however, serology for torovirus was not performed on the above patients while they were hospitalized. consistent as in patients with FMF [9] .
The results of the following laboratory tests were normal or The two patients described herein are unique in their clinical features. Both presented initially with common, nonspecific clininegative: CBC with differential and platelet count, erythrocyte sedimentation rate, electrolyte levels, renal and liver function tests, cal features, namely fever, vomiting, and abdominal pain followed by diarrhea, but then developed severe abdominal pain and acute serum amylase level, and urinalysis. Abdominal and chest radiographs were within normal limits. Abdominal ultrasonography reperitoneal signs. To our knowledge, these signs have not been previously reported in conjunction with a torovirus infection. The vealed free peritoneal fluid. WBCs were seen on microscopic examination of the stool. Stool cultures were negative for bacteria thorough investigations excluded other etiologies of acute abdomen, as no bacterial or other etiologic agent was found, and the and Clostridium difficile cytotoxin. Electron microscopic examination of the stool revealed torovirus. The patient was treated with fact that both patients recovered completely in 2-3 days with conservative treatment alone suggests that this illness was consisbowel rest, intravenous fluids, and intravenous meperidine until her symptoms resolved 3 days later. Repeated examination for tent with a torovirus infection [8] .
Awareness that torovirus may be associated with acute abdomen torovirus in stool 1 month later was negative, and the patient has remained well. The association of borreliosis and thrombocytopenia remains an adenovirus; flavivirus causing seasonal tickborne meningoencephissue of controversy [1, 2] . In a recent review, Nadelman and alitis; Chlamydia; herpes simplex virus; cytomegalovirus; parvoviWormser [3] proposed that thrombocytopenia is not characteristic rus B19; Epstein-Barr virus; and HIV. There was no immunopathoof Lyme borreliosis per se but suggestive of coinfection with spelogical evidence for connective tissue disease. Histological cies of Babesia or Ehrlichia. The few cases of thrombocytopenia evaluation of an iliac crest bone marrow trephine showed hyperplaassociated with borreliosis appear to have been transient, remediasia of megakaryocytes but no other abnormalities. ble by antibiotic therapy, and a consequence of decreased thromboGlycoprotein-specific ELISA showed IgG binding to patient and poiesis [4] . We describe a patient in whom borreliosis triggered donor platelet glycoprotein IIb/IIIa, allowing the diagnosis of autoan autoimmune thrombocytopenia in the absence of coinfection immune thrombocytopenia. Cross-reactivity between Borreliawith Babesia or Ehrlichia species.
specific IgG antibodies and platelets was excluded, since the acid A previously healthy 49-year-old woman from a rural area in eluate of the patient's platelets containing IgG antibodies did not the German state of Baden-Württemberg was admitted for evaluabind to Borrelia-specific proteins in the immunoblot. Furthermore, tion of a 6-month history of recurrent episodes of fever, malaise, incubation of the patient's serum with donor platelets failed to and arthralgia. Easy bruising was not reported. In response to decrease Borrelia-specific IgG levels. specific questioning, the patient recalled a ring-shaped migrating Our patient presented with a history and symptoms typical of rash and a tick bite on the upper trunk 18 months previously.
Lyme borreliosis, confirmed by serological tests. The acute infecExcept for occasional acetaminophen tablets, she had not taken tion probably dates back to one and one-half years ago. Since any medication. Two years previously, a routine platelet count of then, she had developed an autoimmune thrombocytopenia without 220 1 10 9 /L had been recorded by the general practitioner. from all patients and were inoculated into two bottles, one support-
The true incidence of recovery of anaerobes in MAA could not be calculated from our study because of its retrospective nature ive of aerobic growth and the other of anaerobic growth.
and because we included only specimens that were cultured for Microbiology. Eleven organisms, six facultatively aerobic and both aerobic and anaerobic bacteria. The true prevalence of these five anaerobic, were isolated from the eight patients included in organisms in MAA has yet to be investigated by prospective studthe study (table 1) . Aerobic organisms were isolated in only four ies. This is of particular importance, since these organisms are cases, anaerobic organisms in only three, and mixed aerobic and often resistant to the antimicrobials used to treat these infections. anaerobic bacteria in one. Polymicrobial infection was present in three (patients 3, 4, and 6). The predominant bacteria were Staphylococcus species (3 isolates), Enterobacteriaceae (2) , and Itzhak Brook and Edith H. Frazier Peptostreptococcus species (2) . Organisms similar to the ones reDepartment of Infectious Diseases, Navy Hospital, Bethesda, Maryland covered from the MAA were isolated from the blood of four patients. These included one isolate each of S. aureus, Escherichia coli, Bacteroides fragilis, and Clostridium perfringens (table 1) . CID 1999; 28 (April) fungemia in a non-immunocompromised patient without bowel
Fungemia Due to Saccharomyces Species in a Patient
disease who was receiving high doses of enteral Ultra-Levure. As
Treated with Enteral Saccharomyces boulardii
is true for the other reported cases, the primary identification of the Saccharomyces species was incorrect, with the usual confusion As a pharmaceutical biotherapeutic agent, Saccharomyces boulbetween S. boulardii and S. cerevisiae [1, 2, 5] . ardii has been used for years outside of the United States to treat Given that S. boulardii may be initially misidentified as S. cerediarrhea [1] and is considered to be safe. Nevertheless, serious visiae, it is likely that S. boulardii is responsible for saccharomyces side effects can occur. fungemia in patients receiving enteral Ultra-Levure. High doses A 78-year-old immunocompetent woman was admitted to the of Ultra-Levure associated with antibiotics effective against anaerintensive care unit because of an acute exacerbation of chronic obes, bowel diseases, and/or immunodeficiency seem to be risk obstructive pulmonary disease. Current treatment consisted of antifactors for such fungemia; our observation suggests that fungemia biotics (amoxicillin/clavulanic acid), mechanical ventilation, and due to Saccharomyces species can also occur in immunocompetent enteral feeding via a gastric tube. On hospital day 12, diarrhea hosts without bowel disease. Enteral S. boulardii is widely used appeared. Investigation for stool pathogens was negative; loperain the prevention or treatment of diarrhea; therefore, physicians mide and S. boulardii (Ultra-Levure, 1.5 g/day [Biocodex, Monmust be aware of the possibility of potentially serious side effects. trouge, France]) were administered via the gastric tube (day 13)
The reported occurrence of such side effects is infrequent at presfor 15 days. On day 18, antibiotic therapy was changed to that with ent, and no current guidelines exist for their treatment. ceftazidime and ciprofloxacin because of a nosocomial pulmonary infection. On day 34, the temperature was elevated to 39ЊC and M. Niault, F. Thomas, J. Prost, F. Hojjat Ansari, and the WBC count was 8,600/mm 3 . From day 34 to day 37, seven P. Kalfon cultures of blood were positive for Saccharomyces species; the 
Type 1 in the Central Nervous System
CSF and plasma viral loads remained undetectable.
To improve the quality of life for our patient, we decided to Foscarnet, a reverse transcriptase inhibitor, has been shown to interrupt foscarnet administration without modifying the rest of decrease HIV-1 replication in vitro [1, 2] . Recently, reports of two the treatment. A lumbar puncture performed 2 weeks later showed studies about the effects of this antiviral agent on HIV replication a detectable HIV RNA viral load at 3 log 10 copies/mL. A third in vivo were published [3, 4] . Both investigators observed signifiepisode of mental dysfunction, associated with an important rise cant reductions of HIV plasma viral loads in patients who were in CSF viral load (5.1 log 10 RNA HIV copies/mL), occurred 6 treated with foscarnet. Herein, we report an observation that foscarweeks after stopping foscarnet. Therapy was switched to that with net is also active in the CNS when used to treat HIV encephalonew drugs available at this time, abacavir, nevirapine, and nelfipathy-related symptoms. navir, with successful clinical and virological response. A 55-year-old HIV-1-infected man with a Burkitt's lymphoma Foscarnet has been shown to penetrate the blood-brain barrier was treated with indinavir (800 mg t.i.d.) and saquinavir (400 mg [5] . In our patient, foscarnet was highly effective in reducing the b.i.d.). Therapy with this combination of two protease inhibitors CSF HIV viral load and neurological symptoms, and this effect was started during multidrug chemotherapy for his lymphoma to was sustained throughout the 3 months of therapy. The CSF HIV avoid myelotoxicity induced by nucleoside analogs. Since the RNA load rebounded 2 weeks after cessation of therapy, and cliniplatelet count remained low (30,000/mm 3 ) and plasma HIV viral cal symptoms reappeared a few weeks later. load was undetectable, antiretroviral therapy was not modified after
The CNS is a protected compartment, known to be difficult to completion of the antineoplastic treatment, which led to complete reach, since antiretroviral drugs like protease inhibitors do not remission. The CD4/ cell count was 150/mm 3 . cross the blood-brain barrier efficiently. This phenomenon is illusThe patient works as a translator. Six months after beginning trated in the case we described, given the occurrence of neurologitherapy with protease inhibitors, he experienced a first episode of cal symptoms associated with a high CSF viral load despite undesomnolence, lack of concentration, and inability to work. Brain tectable HIV RNA in plasma. In our patient, clinical evolution CT scan and MRI showed no abnormalities. A CSF specimen paralleled changes in CSF HIV RNA, indicating that high CSF contained 3 lymphocytes/mm 3 and protein levels were normal. viral loads can be a marker of HIV encephalopathy. Our observaMicroscopic examination and cultures of CSF were negative for tion suggests that foscarnet might be helpful for the treatment bacteria, parasites, and fungi. A search for neoplastic cells and of HIV-associated mental deterioration in cases of resistance or cryptococcal antigen was negative. A PCR assay of CSF was intolerance to all antiretroviral drugs known to be active in negative for herpes simplex virus types 1 and 2, cytomegalovirus the CNS. (CMV), JC virus, and Toxoplasma gondii. The CSF HIV viral load was 4.23 log 10 HIV RNA copies/mL, whereas the plasma viral Marie-Luce Delforge, Claire-Michèle Farber, load was still undetectable. Zidovudine at low doses (100 mg t.i.d.)
Frédéric De Leener, Jean-Marc Caroyer, was added to the treatment. After 2 weeks, the patient regained Corinne Liesnard, and Jean-Paul Van Vooren his fluency in six languages, and CSF HIV viral load levels de- 
